Study identification

PURI

https://redirect.ema.europa.eu/resource/104832

EU PAS number

EUPAS104709

Study ID

104832

Official title and acronym

The UK nationwide cardiorespiratory impact of the COVID-19 pandemic

DARWIN EU® study

No

Study countries

Argentina
Australia
Bulgaria
Canada
Colombia
Denmark
Greece
India
Ireland
Korea, Republic of
Kuwait
Mexico
Portugal
Saudi Arabia
Spain
Taiwan
United Arab Emirates
United Kingdom
United States

Study status

Planned
Research institution and networks

Institutions

Contact details

David Price

Primary lead investigator
Study timelines

Date when funding contract was signed

Planned:

Study start date

Planned:

Date of final study report

Planned:
Sources of funding
Other

More details on funding

Observational and Pragmatic Research Institute UK
Regulatory

Was the study required by a regulatory body?

No

Is the study required by a Risk Management Plan (RMP)?

Not applicable